Nuove sostanze d'abuso sul Web : Il ruolo dello Psychonaut Web Mapping Project

Schifano, Fabrizio; Corazza, Ornella; Ricciardi, A.; Rafanelli, C.; Deluca, P.; Davey, Z.; Di Furia, L.; Farrè, M.; Flesland, L.; Mannonen, M.; Peltoniemi, T.; Pezzolesi, C.; Pagani, S.; Scherbaum, N.; Siemann, H.; Skutle, A.; Torrens, M.; Van Der Kreeft, P.

Author

Schifano, Fabrizio

Corazza, Ornella

Ricciardi, A.

Rafanelli, C.

Deluca, P.

Davey, Z.

Di Furia, L.

Farrè, M.

Flesland, L.

Mannonen, M.

Peltoniemi, T.

Pezzolesi, C.

Pagani, S.

Scherbaum, N.

Siemann, H.

Skutle, A.

Torrens, M.

Van Der Kreeft, P.

Abstract

In the rapid change of drug scenarios, as the powerful development in the drug market, particularly in the number and the kind of the compound available, Internet plays a dominant role to become one of the major "drug market". The European Commission funded the Psychonaut Web Mapping Project (carried out in the time-frame January 2008-December 2009), with the aim to start/implement an Early Warning System (through the data/information collected from the Web virtual market), to identify and categorise novel recreational drugs/psychoactive compounds (synthetical/herbal drugs), and new trends in drug use to provide information for immediate and prevention intervention.The Psychonaut is a multi-site research project involving 8 research centres (De Sleutel, Belgium; University of Hertfordshire School of Pharmacy, St George's University of London, England; A-klinikkasäätiö, Finlandia; Klinik für Psychiatrie und Psychotherapie, Germany; Assessorato Salute Regione Marche, Italy; Drug Abuse Unit, Spain; Centre of Competence Bergen Clinics Foundation, Norway) based in 7 European Countries (England, Italy, Belgium, Finland, Germany, Spain, Norway).